Literature DB >> 22417234

A simple strategy for screening for glucose intolerance, using glycated haemoglobin, in individuals admitted with acute coronary syndrome.

N Gholap1, M J Davies, S A Mostafa, I Squire, K Khunti.   

Abstract

Glucose intolerance is common but often remains undiagnosed and untreated in people with acute coronary syndrome. The best approach to screening for glucose intolerance post-acute coronary syndrome remains debated. The World Health Organization has recently advocated the use of HbA(1c) in diagnosing Type 2 diabetes. A screening strategy using HbA(1c) as the preferred test would be pragmatic and improve early detection and management of glucose intolerance in acute coronary care practice. In this commentary, we discuss the relevant literature and guidelines in this area and propose a simple and pragmatic algorithm based on the use of HbA(1c) to screen for glucose intolerance during and after admission with acute coronary syndrome.
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22417234     DOI: 10.1111/j.1464-5491.2012.03643.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

Review 1.  Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Maria Grazia D'Alfonso; Gian Franco Gensini
Journal:  World J Cardiol       Date:  2014-04-26

2.  HbA1c screening for new onset diabetes following acute coronary syndrome: is it a worthwhile test in clinical practice?

Authors:  Sebastian T Lugg; Christine J H May; Peter Nightingale; Robbie P E Tuffley; June Al-Hourani; Parijat De
Journal:  J Diabetes Metab Disord       Date:  2017-04-04

3.  HbA1c for Diabetes Screening in Acute Coronary Syndrome: time for a reappraisal of the guidelines?

Authors:  C McCune; S Maynard; B McClements; J R Lindsay
Journal:  Ulster Med J       Date:  2015-10

4.  Time-saving screening for diabetes in patients with coronary artery disease: a report from EUROASPIRE IV.

Authors:  Viveca Gyberg; Dirk De Bacquer; Kornelia Kotseva; Guy De Backer; Oliver Schnell; Jaakko Tuomilehto; David Wood; Lars Rydén
Journal:  BMJ Open       Date:  2016-12-08       Impact factor: 2.692

5.  Cell-free long non-coding RNAs (LY86-AS1 & HCG27_201and GAS5) as biomarkers for pre-diabetes and type 2 DM in Egypt.

Authors:  Amany A Saleh; Heba E Kasem; Enas S Zahran; Sally M El-Hefnawy
Journal:  Biochem Biophys Rep       Date:  2020-06-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.